Cerus Corp.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Cerus Corp.
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.
Frequently asked questions
To buy Cerus Corp. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Cerus Corp. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Cerus Corp. is CERS:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Cerus Corp. has its primary listing on NASDAQ. You can trade Cerus Corp. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Cerus Corp. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Cerus Corp. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Cerus Corp..